Or click and collect!
Or click and collect!
Inflammation is the body's primary defence mechanism but when it is sustained chronically by ongoing exposure to inhaled substances, it becomes a health concern in its own right. Here is what the evidence shows about vaping's relationship with inflammation.
Regular vaping produces a measurable inflammatory response in the airways and, to a lesser degree, systemically. Studies comparing vapers with non-smoking non-vapers find elevated airway inflammatory cell counts, increased inflammatory cytokines in exhaled breath condensate, and in some studies modest elevation of systemic inflammatory markers. These effects are substantially lower in magnitude than the inflammatory response produced by tobacco smoking, which causes severe, progressive airway and systemic inflammation through combustion carcinogens. The long-term clinical significance of vaping-induced inflammation at current measurement levels is still being studied.
The most directly measurable inflammatory effect of vaping is in the airways. Bronchoalveolar lavage studies in vapers show elevated neutrophil counts and inflammatory cytokines compared to non-vapers. This inflammatory activity in the bronchial mucosa and alveoli is the immune system's response to inhaled foreign substance, a normal protective reaction that becomes a chronic low-grade state with regular vaping. The degree of inflammation is substantially lower than in smokers, whose airways show severe inflammatory remodelling from years of combustion product exposure, but it is measurably above the non-vaper baseline.
Nicotine and some vapour components can affect endothelial function, the inner lining of blood vessels. Some studies have found reduced flow-mediated dilation (a measure of vascular health) in vapers compared to non-vapers, suggesting a mild vasoinflammatory effect. This is less severe than the vascular inflammation caused by tobacco combustion products, which trigger platelet aggregation, oxidise LDL cholesterol and drive atherosclerotic plaque development. The vascular inflammatory picture for vapers falls between non-vapers and smokers in most studies.
Some but not all studies measuring systemic inflammatory markers, including C-reactive protein, interleukin-6 and other biomarkers, in vapers find modest elevations compared to non-vapers. The evidence is less consistent here than for airway inflammation, partly because systemic inflammation has many causes and isolating the vaping contribution is methodologically challenging. The current evidence suggests vaping's systemic inflammatory effect is modest and substantially lower than smoking's.
Nicotine itself has pro-inflammatory properties, it activates inflammatory signalling pathways in several cell types. This means that even nicotine-free vaping reduces but does not eliminate the inflammatory signal from vapour inhalation. The nicotine and the vapour compounds both contribute to the overall inflammatory response, with nicotine being a significant factor in the vascular effects in particular.
We take the health evidence seriously and give honest answers to questions about long-term vaping effects.
To find our Coventry store, visit our Vape Shop Coventry page.
Our Health guide covers vaping and inflammation, lung health, cardiovascular effects and the broader long-term health evidence base.
Find more health evidence guides in our Health guide.
We do not dismiss or minimise the evidence. Come in for a real conversation.